Dec 4, 2023 4:05pm EST Sutro Biopharma to Participate in the JMP Securities Hematology and Oncology Summit
Nov 27, 2023 4:00pm EST Vaxcyte Exercises Option and Enters into Manufacturing Rights Agreement with Sutro Biopharma to Obtain Control Over Manufacturing and Development of Cell-Free Extract for its Vaccine Candidates